BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marcelissen T, Cornu JN, Antunes-Lopes T, Geavlete B, Delongchamps NB, Rashid T, Rieken M, Rahnama'i MS. Management of Idiopathic Overactive Bladder Syndrome: What Is the Optimal Strategy After Failure of Conservative Treatment? Eur Urol Focus 2018;4:760-7. [PMID: 29807823 DOI: 10.1016/j.euf.2018.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lu JH, Chueh KS, Chuang SM, Wu YH, Lin KL, Long CY, Lee YC, Shen MC, Sun TW, Juan YS. Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome. Biology (Basel) 2021;10:540. [PMID: 34208659 DOI: 10.3390/biology10060540] [Reference Citation Analysis]
2 Dequirez PL, Biardeau X. Randomized clinical trials assessing third-line therapies to treat non-neurogenic overactive bladder syndrome: a review about methodology. Int Urogynecol J 2021. [PMID: 33770228 DOI: 10.1007/s00192-021-04688-z] [Reference Citation Analysis]
3 Reekmans M, Janssen JMW, Vrijens DMJ, Smits MAC, van Koeveringe GA, Van Kerrebroeck PEVA. Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients. Neurourol Urodyn 2021;40:1120-5. [PMID: 33829519 DOI: 10.1002/nau.24670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lee YC, Chuang SM, Lin KL, Chen WC, Lu JH, Chueh KS, Shen MC, Liu LW, Long CY, Juan YS. Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study. Biomed Res Int 2020;2020:9175676. [PMID: 32724817 DOI: 10.1155/2020/9175676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wu YH, Chueh KS, Chuang SM, Long CY, Lu JH, Juan YS. Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants. Int J Mol Sci 2021;22:6014. [PMID: 34199527 DOI: 10.3390/ijms22116014] [Reference Citation Analysis]
6 Baron M, Perrouin-Verbe MA, Lacombe S, Paret F, Le Normand L, Cornu JN. Efficacy and tolerance of botulinum toxin injections after sacral nerve stimulation failure for idiopathic overactive bladder. Neurourol Urodyn 2020;39:1012-9. [PMID: 32108383 DOI: 10.1002/nau.24326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Tu LM, De Wachter S, Robert M, Dmochowski RR, Miller LE, Everaert K. Initial clinical experience with selective bladder denervation for refractory overactive bladder. Neurourol Urodyn 2019;38:644-52. [PMID: 30499155 DOI: 10.1002/nau.23881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]